The mechanism of action/pharmacodynamics of ELIDEL Cream and the inflammatory cascade.6,8
Targets Cells Involved in Skin InfIammation
- The mechanism of action of ELIDEL Cream in eczema is unknown.6
- In vitro, it has been demonstrated that pimecrolimus inhibits calcineurin and thus inhibits
T cell activation by blocking the transcription of inflammatory cytokines.6,8*
- Pimecrolimus has an immunosuppressant action and targets cells involved in skin inflammation.6
*The clinical significance of in vitro data has not been established.
With ELIDEL, systemic absorption of pimecrolimus is low. Learn More.